labs
Lab Timeline
Lab Timeline
Chronological log of all lab results (newest first).
| Date | Panel/Test | Key Findings | Source |
|---|---|---|---|
| 2026-06-01 | CBC (KIMS) | WBC 2200 (L ↓ — DEEPEST NADIR since stabilization), ANC 990 (L — SEVERE NEUTROPENIA, Grade 3 <1000), Hb 11.3 (L ↓ — dropped back below normal from 12.0), Plt 252 (N ↑ — FULLY RECOVERED +145K from May 27). Polymorphs 46% (lowest on record), Lymphs 42.8% (relative lymphocytosis), Monos 5.6%, Eos 3.7%, Baso 1.9% (H). ALC 920 (L), AMC 120 (L), AEC 80 (L), ABC 40 (L). RBC 3.53 (L ↓), Hct 35.3% (L), MCV 100 (H — HIGHEST KIMS MCV ON RECORD; worsening macrocytosis), MCH 32 (N), MCHC 32 (N), RDW 18.3% (H). MPV 11.1 (upper normal). Bill L041256126. Dr. Bijay Prabhakaran Nair. Collected 11:11 AM. CRITICAL: SEVERE NEUTROPENIA (ANC 990) — deepest nadir since March 2026 stabilization. CRITICALLY ELEVATED infection risk. Acyclovir + posaconazole prophylaxis ESSENTIAL. Lineage dissociation confirmed: platelets fully recovered (252K) while granulocytes at nadir. Hb dropped (hemodilution or erythroid lag). MCV 100 fL signals worsening macrocytosis (azacitidine effect + stress erythropoiesis). Recovery expected within 3-7 days (~June 4-8). | raw/labs/2026-06-01_Ishamma_T_M.pdf |
| 2026-05-27 | CBC + Electrolytes (KIMS) | Hb 12.0 (N — FIRST NORMAL Hb since AML diagnosis ↑ +0.4 from May 23), WBC 2400 (L ↓ — deepening leukopenia), Plt 107 (L — minor dip from 117, stabilizing), ANC 1460 (L — MODERATE NEUTROPENIA, below 1500 threshold). Polymorphs 61.3%, Lymphs 31.1%, Monos 5.6%, Eos 1.3%, Baso 0.8%. ALC 740 (L), AMC 130 (L). RBC 3.77 (L), Hct 35.8%, MCV 95 (H), MCH 31.8 (N), MCHC 33.5 (N), RDW 17.8% (H). MPV 11 (upper normal). Na 137 (N), K 4.4 (N), Cl 98 (N — lower limit), HCO3 28 (N). Bill L040020926. Dr. Bijay Prabhakaran Nair. Collected 10:42 AM. WBC/ANC NADIR CONFIRMED. Lineage cascade May 2026: Plt nadir May 11 → Hb nadir May 17 → ANC nadir May 27. Hb paradoxically at first-ever normal (12.0). Infection risk elevated (ANC 1460). Prophylaxis (acyclovir + posaconazole) critical. | raw/labs/20260527_Ishamma T M 1 5-27-2.pdf |
| 2026-05-23 | CBC + Electrolytes (KIMS) | Hb 11.6 (L ↑ +1.7 from May 17 nadir), WBC 3500 (L ↓ — leukopenia continuing), Plt 117 (L ↑ +14K from May 17 — recovering), ANC 2430 (N borderline — −970 from May 17). Polymorphs 68.8%, Lymphs 24.1%, Monos 4.5%, Eos 2.3%, Baso 0.3%. ALC 850 (L), AMC 160 (L). RBC 3.76 (L), Hct 35.6%, MCV 94.7 (H), MCH 30.9 (N), MCHC 32.6 (N), RDW 18.0% (H). MPV 10 (N). Na 141 (N), K 4.6 (N), Cl 99 (N), HCO3 29.5 (H — borderline, above upper limit 29). Bill L038904126. Smear checked. Dr. Bijay Prabhakaran Nair. Collected 09:41 AM. Intermediate panel: Hb recovering from nadir, WBC/ANC continuing to decline toward nadir (reached May 27). Bicarbonate mildly elevated. | raw/labs/20260527_Ishamma T M 5-27-1.pdf |
| 2026-05-17 | CBC + Electrolytes (KIMS) | Hb 9.9 (L — SEVERE DROP −1.9 from May 11; NADIR; back to mid-March levels), WBC 4600 (N — declining −1100), Plt 103 (L — continued thrombocytopenia, borderline <100K), ANC 3400 (N — declining −550). Polymorphs 74.7%, Lymphs 16.3% (L). RBC 3.17 (L — SEVERE DROP −0.56), Hct 30%, MCV 94.6 (H), RDW 17.8% (H). Na 140 (N), K 4.7 (N), Cl 103 (N — normalized), HCO3 25.7 (N — normalized). Bill L037179526. Dr. Bijay Prabhakaran Nair. Severe erythroid nadir; electrolytes fully normal. WBC/ANC nadir pending. Lineage cascade: Plt nadir May 11 → Hb/RBC nadir May 17. | raw/labs/2026-05-17_Ishamma_T_M_1.pdf |
| 2026-05-11 | CBC + Electrolytes + Magnesium (KIMS) | Hb 11.8 (L, stable −0.1), WBC 5700 (N ↑ from 4000), Plt 113 (L — sharp drop ↓ from 213 — new thrombocytopenia), ANC 3950 (N ↑ from 2360). Polymorphs 69.3%, Lymphs 20.2%, Monos 5.8%, Eos 4.2%, Baso 0.5%. ALC 1150, AMC 330, AEC 240, ABC 30. RBC 3.73 (L), Hct 36.1%, MCV 96.8 (H), MCH 31.6, MCHC 32.7, RDW 18.2% (H). MPV 9.8. Na 137 (N — stable from 142), K 4.5 (N), Cl 96 (L — re-dropped from 103), HCO3 29.1 (H borderline — at upper limit 29), Mg 1.5 (L — re-dropped from 1.6). Bill L035372426. Dr. Bijay Prabhakaran Nair. Collected 08:07 AM. Dissociated lineage kinetics: Plt dropped sharply while WBC/ANC remain elevated — early Aza-Ven myelosuppression. Electrolyte disturbance recurring: Mg and Cl re-dropped. | raw/labs/2026-05-11_Ishamma_T_M_A.pdf |
| 2026-05-04 | CBC + Electrolytes + Magnesium (KIMS) | Hb 11.9 (L, improved ↑ from 11.4), WBC 4000 (N — recovered from 3000), Plt 213 (N — stable ↑ from 196), ANC 2360 (N — recovered from 1990). Polymorphs 59.0%. RBC 3.79 (L — closest to normal since AML), Hct 36.3%, MCV 95.8 (H), RDW 18.3% (H). Na 142 (N — normalized from 134), K 4.0 (N), Cl 103 (N — normalized from 95), HCO3 24.0 (N), Mg 1.6 (N — normalized from 1.4). Bill L033433126. Multi-lineage recovery + electrolyte normalization (Na, Cl, Mg all normalized). | raw/labs/2026-05-04_Ishamma_T_M.pdf |
| 2026-04-22 | Fructosamine, Serum (Dr Lal PathLabs NRL) | Fructosamine 310 µmol/L (HIGH) — ref 122–236. Indicates suboptimal short-term glucose control (1–2 weeks). Contradicts improving HbA1c trend — suggests HbA1c improvement (6.8% → 5.7%) is spurious due to altered RBC turnover from AML treatment. True diabetes likely persists with poor control. Sent to National Reference Lab, Delhi. Lab No. 515013880. Collected 2026-04-22 09:19, reported 2026-04-23 16:50. Ref: Bijay Prabhakaran Nair. | raw/labs/2026-04-29_ISHAMMA.pdf |
| 2026-04-27 | CBC + Electrolytes + Magnesium (KIMS) | Hb 11.4 (L, stable), WBC 3000 (L ↓ from 4100), Plt 196 (N — strong recovery ↑ from 99), ANC 1990 (L — mild neutropenia ↓ from 2970). RBC 3.66 (L, stable), MCV 94 (H), MCH 31.1 (N), MCHC 33.1 (N), RDW 18.6 (H ↑ from 17.6), MPV 10.3 (N). ALC 680 (L — lymphopenia, stable). Basophils 1.3% (H, mild). Na 134 (L — improved ↑ from 128), K 4.6 (N), Cl 95 (L, marginal improvement), HCO3 26.7 (N, improved ↑ from 22.8). Mg 1.4 (L — improved ↑ from 1.2). Bill L031606726. Sample collected 01:33 PM, authorized 01:58–02:50 PM. | raw/labs/20260427_Ishamma T M 1 ok.pdf |
| 2026-04-20 | CBC + Electrolytes + Magnesium (KIMS) | Hb 11.4 (L), WBC 4100 (N ↑ from 3500), Plt 99 (L — new concern ↓ from 140), ANC 2970 (N). RBC 3.62 (L), MCV 93.1 (H), MCH 31.5 (N), MCHC 33.8 (N), RDW 17.6 (H), MPV 9.9 (N). ALC 690 (L — lymphopenia). Na 128 (L — new nadir ↓ from 133), K 4.7 (N), Cl 93 (L), HCO3 22.8 (N, low end). Mg 1.2 (L — new low ↓ from 1.4). Bill L029731026. Auth: Greeshma M Nair (electrolytes), collected 02:25 PM. | 20260420_Ishamma T M today.pdf |
| 2026-04-13 | CBC + Electrolytes (KIMS) | Hb 10.5 (L), WBC 3500 (L), Plt 140 (L), ANC 2590. Na 133 (L), K 4.8, Cl 94 (L), HCO3 27.2 | Ishamma T M 1.pdf |
| 2026-04-06 | CBC + Electrolytes + LFT + Renal (KIMS) | Hb 11.6 (L), WBC 5400, Plt 131 (L), ANC 4020. Na 132 (L), K 4.4, Cl 93 (L), HCO3 24.5. LFT: TBil 0.2, DBil 0.1, ALT 11, AST 15, ALP 63, TP 7.3, Alb 4.4, Glob 2.89 — all normal. BUN 13.4 (N), Cr 0.6 (N). Cycle 4+ start. Bill L025985226. | Ishamma T M.pdf |
| 2026-03-30 | CBC + Electrolytes (KIMS) | Hb 11.3 (L), WBC 4300, Plt 164, ANC 2610. Na 135 (L), K 4.8, Cl 94 (L), HCO3 28.6 | Ishamma T M 2.pdf |
| 2026-03-25 | CBC + Electrolytes (KIMS) | Hb 10.9 (L), WBC 5400, Plt 279, ANC 3740. Na 132 (L), K 4.2, Cl 94 (L), HCO3 23.9 | Ishamma T M 1 2.pdf |
| 2026-03-18 | CBC + Electrolytes (KIMS) | Hb 10.1 (L), WBC 6000, Plt 102 (L), ANC 4560. Na 133 (L), K 4.7, Cl 96 (L), HCO3 26.8 | Ishamma T M 1 3.pdf |
| 2026-03-12 | CBC + Electrolytes (KIMS) | Hb 10.0 (L), WBC 7100, Plt 78 (L), ANC 5650. Na 129 (L — nadir), K 4.4, Cl 94 (L), HCO3 24.4 | Ishamma T M 1 4.pdf |
| 2026-03-05 | CBC + Electrolytes (KIMS) | Hb 9.7 (L), WBC 3500 (L), Plt 102 (L), ANC 2320. Na 132 (L), K 4.7, Cl 97 (L), HCO3 23.9. Smear checked. | Ishamma T M 3.pdf |
| 2026-03-02 | Comprehensive panel (KIMS) | Hb 10.5 (L), WBC 3000 (L), Plt 101 (L), ANC 1840 (L). HbA1c 5.7%. Na 135 (L), K 4.9, Cl 96 (L), HCO3 27.4. Cr 0.7 (N). Ca 9.9 (N). Mg 1.4 (L). LFT: TBil 0.3, DBil 0.2, ALT 11, AST 16, ALP 60 — all normal. Lipids: TC 173, TG 131, HDL 62.6, LDL 98, VLDL 26 — all normal (random). Auth: Greeshma M Nair. | Ishamma T M 4.pdf |
| 2026-02-25 | CBC (KIMS) | Hb 10.5 (L), WBC 2400 (L), Plt 106 (L), ANC 1270 (L — neutropenic) | Ishamma T M 5.pdf |
| 2026-02-23 | CBC + ESR (DDRC Agilus) | Hb 10.8 (L), WBC 2300 (L), Plt 80 (L — rechecked on smear), ANC 1290 (L), ESR 60 (H). RBC 3.37 (L), MCV 97.7, MCH 32.1 (H), RDW 16.8 (H). ALC 870 (L), AMC 50 (L). Reported by Dr. Vaishali Rajan. | Report For Accession No 4170ZB001398.pdf |
| 2026-02-20 | CBC + ESR (DDRC Agilus) | Hb 10.6 (L), WBC 1600 (critical), Plt 150, ANC 880 (L — severe neutropenia), ESR 40 (H), MCV 99.8, RDW 16.7 (H) | 4170ZB0011814170_849900t.pdf |
| 2026-02-17 | CBC (KIMS) | Hb 10.2 (L), WBC 1600 (L), ANC 610 (L — severe neutropenia) | Ishamma 1.pdf |
| 2026-02-10 | CBC + Electrolytes (KIMS) | Hb 9.8 (L), WBC 1300 (nadir), Plt 262, ANC 680 (L). Na 137, K 4.4, Cl 96 (L), HCO3 27.1 | Ishamma T M 6.pdf |
| 2026-02-04 | CBC + Electrolytes (KIMS) | Hb 8.8 (L), WBC 4100, Plt 300, ANC 3520. Na 137, K 3.5 (low-normal), Cl 98, HCO3 25.6 | Ishamma T M 1 5.pdf |
| 2026-01-31 | CBC + Electrolytes (KIMS) | Hb 8.3 (L), WBC 4200, Plt 225, ANC 2860. Na 134 (L), K 3.9, Cl 97 (L), HCO3 26.3 | Ishamma T M 7.pdf |
| 2026-01-28 | CBC + Electrolytes (KIMS) | Hb 9.6 (L), WBC 4000, Plt 248, ANC 3220. Na 134 (L), K 3.6, Cl 94 (L), HCO3 24.4 | Ishamma T M 1 6.pdf |
| 2026-01-25 | CBC + Electrolytes (KIMS) | Hb 8.7 (L), WBC 5900, Plt 224, ANC 4670. Na 136, K 4.5, Cl 100, HCO3 25.1. RBC 2.85 (L), MCV 96.5 (H), RDW 18.3 (H). ALC 570 (L). | Ishamma T M 8.pdf |
| 2026-01-22 | CBC + Creatinine + Calcium (KIMS) | Hb 9.6 (L), WBC 6800, Plt 257, ANC 5410. RBC 3.14 (L), MCV 96.8 (H), RDW 18.8 (H). ALC 500 (L). Cr 0.9 (N). Ca 10.1 (N). | Ishamma T M 9.pdf |
| 2026-01-19 | CBC + LFT + Electrolytes + Ca/Cr (KIMS) | Hb 11.0 (L), WBC 5000, Plt 358, ANC 3260. LFT: TBil 0.4, DBil 0.2, ALT 14, AST 19, ALP 77, TP 7.6, Alb 4.4, Glob 3.2 — all normal. Na 136, K 4.7, Cl 96 (L), HCO3 26.4. Ca 10.7 (H). Cr 0.8 (N). Cycle 2 start. Bill L005244326. | Ishamma T M 1 7.pdf |
| 2026-01-16 | CBC (KIMS) | Hb 9.0 (L), WBC 5400, Plt 327, ANC 3620 | Ishamma T M 10.pdf |
| 2025-12-31 | Bone marrow biopsy (KIMS) | Day 21 BMBx: cellularity 60%→25-30%, reticulin improved Grade 1-2→1. Treatment response. | Bone Marrow Biopsy 2025 12 31 |
| 2025-11-17 | PBF + Folic Acid + Iron Profile (KIMS) | Peripheral blood film: Pancytopenia — moderate anemia (normocytes + macrocytes), moderate leukopenia (eosinophils 18%), moderate thrombocytopenia. No haemoparasites. Folic acid >20 ng/ml (N). Transferrin 1.86 g/L (L), TSAT 16.5% (N) — anemia of chronic disease pattern. Ref: Mithun Padmanabhan. Reported by Dr. Padmini R. | Ishamma T M 12.pdf, Ishamma T M 13.pdf |
| 2025-07-05 | Pre-AML metabolic panel (Devi Scans) | Lipid panel: TC 165 (N), TG 101 (N), HDL 69 (high/good), LDL 75 (N). HbA1c 6.7% (DM). Calcium 10.20 (N). Creatinine 0.62 (N). Urea 26 (N). Na 138.8 (N), K 4.13 (N). Approved by Dr. Soumya Jose. | ISHAMMA T M 14.pdf |
| 2025-11-28 | CBC + BMBx + Flow (KIMS) | Hb 6.8 (L — nadir), WBC 2500 (L), Plt 45 (L — severe), ANC 1240 (L). BMBx: AML dx confirmed. Flow: ~5% blasts. | File1000384802.pdf |
| 2025-11-22 | Oncomine Myeloid Assay NGS (Agilus Diagnostics, Gurugram) | Bone marrow sample drawn 2025-11-22. Reported 2025-11-27. 69-gene panel (DNA+RNA). 6 variants detected: RUNX1 p.Asp93GlyfsTer32 (4% VAF, Tier I), ASXL1 p.Trp1411Ter (28%, Tier I), BCOR p.Arg810Ter (17%, Tier I), SRSF2 p.Pro95His (31%, Tier I), STAG2 p.Met1102TyrfsTer34 (16%, Tier I), NRAS p.Gly12Asp (3%, Tier II). No RNA fusions. Coverage 3345x, uniformity 99.54%. Classified: AML, myelodysplasia-related (WHO/ICC 2022). Adverse-risk. Ref: Ashwin V Nair. | ISHAMMA T M (MR000384802).pdf |
| 2025-11-20 | Bone marrow biopsy (KIMS) | BMBx #1 — diagnostic. Biopsy No B25-15264. 60% cellularity, atypical mononuclear infiltrate, reticulin Grade 1–2. Authorized 2025-11-26 by Dr. Neetu S Dathan. | Bone Marrow Biopsy 2025 11 20 |
| 2025-11-19 | Comprehensive panel (DDRC Agilus) | Hb 8.3 (L), WBC 2320 (L), Plt 70 (L), ANC 1090 (L), ESR 130 (H), CRP 13.8 (H), HbA1c 6.8% (DM), Retic 1.6% (N), Ceruloplasmin 29.1 (N), Copper 124.5 (N), C3 140 (N), C4 39.3 (N), Anti-CCP <7 (N), ANA 2.2 (positive), Anti-dsDNA 29.1 (negative), SPEP: inflammatory, no M-spike, Free light chains: K 36.81 (H), L 26.73 (H), ratio 1.377 (N). Peripheral smear: pancytopenia with eosinophil predominance. | Multiple DDRC reports |
| 2022-09-27 | CBC + ESR + CRP + IgE (DDRC SRL) | Hb 11.0 (L), WBC 9550, Plt 501 (H — reactive), ESR 62 (H), CRP 4.89 (N — resolving), IgE 134.4 (H). Recovery phase. | 4182VI0131054182_816476x.pdf |
| 2022-09-20 | CBC + ESR + CRP + IgE + D-Dimer (DDRC SRL) | WBC 14770 (H), ESR 119 (H), CRP 128.13 (H — acute inflammation), IgE 203.1 (H), D-Dimer 0.48 (N). Ref: Sudheendra Ghosh. | 4182VI0091894182_910394a.pdf |